---
格式版本: 2
标题: "Google DeepMind expands biosecurity effort amid AI safety push"
原文链接: "https://www.axios.com/2026/07/16/google-deepmind-biosecurity-safety"
发布日期: "2026-07-16"
发布时间校准状态: "found"
发布时间来源: "llm:strict_local_body"
发布时间证据: "Jul 16, 2026 \\- Technology"
发布时间校准原因: "该日期位于标题下方/作者区域，是Axios文章的标准发布时间格式，且与URL路径一致，确认为文章发布时间。"
发布时间校准置信度: "100"
发布时间候选数量: 16
发布时间严格候选数量: 2
发布时间原页读取状态: "原页面来自已抓取 HTML"
发布时间未找到原因: "候选日期无效或 LLM 未确认"
发布时间校准时间: "2026-07-20T02:20:27+08:00"
发现时间: "2026-07-19T17:46:25+08:00"
入库时间: "2026-07-19T18:30:42.537Z"
来源平台: "Tavily（AgentKey）"
搜索渠道: "tavily_web"
搜索词: "Google"
匹配关键词:
  []
相关厂家:
  - "Google"
相关专家:
  []
内容类型: "网页"
抓取工具: "AgentKey Scrape"
清洗工具: "AgentKey Markdown + LLM 正文裁剪"
原始附件:
  []
AI优质: "否"
AI打分: 25
AI分档: "非优质"
AI质检状态: "不通过"
AI打分理由: "文章讨论Google DeepMind的生物安全与AI监管政策，与超节点/AI Rack/机柜级AI基础设施、硬件架构、供电散热互连等核心主题完全无关。虽为Axios报道，但内容不涉及任何AI基础设施技术或商业部署信息。"
AI质检模型: "qwen3.6-plus"
AI质检时间: "2026-07-20T02:30:42+08:00"
AI主题相关性: 0
AI来源权威性: 10
AI新颖性: 10
AI技术细节: 0
AI商业部署信号: 0
AI完整性: 5
图片摘要:
  - "✗ ./assets/img-e802706b.webp | decorative | 装饰性概念插图，无具体数据或技术信息"
采集批次: "2026年7月19日17点45分46秒"
采集批次ID: "20260719-174546-694"
去重键: "https://www.axios.com/2026/07/16/google-deepmind-biosecurity-safety"
---

## Exclusive: Google bets that AI can stop bioweapons

- email (opens in new window)
- sms (opens in new window)
- facebook (opens in new window)
	twitter (opens in new window)
	linkedin (opens in new window)
	bluesky (opens in new window)

![Illustration of a robot hand holding up a beaker to the light with a glowing liquid inside.](./assets/img-e802706b.webp)

Illustration: Aïda Amer/Axios

Google DeepMind on Thursday unveiled a new bioresilience program designed to help governments and researchers prevent, detect and respond to biological threats.

**Why it matters:** Google is betting the same frontier AI models that could create new biological risks can also help prevent them.

content frame

**An error has occurred**

Axios AI+: Catch up on what's new and why it matters in just 5 minutes.

Sign up for Axios AI+ to continue reading for free.

**The big picture:** DeepMind's announcement comes days after DeepMind CEO [Demis Hassabis](https://www.axios.com/2026/07/14/demis-hassabis-ai-regulation-google-deepmind) told Axios that governments should establish a standards body for frontier AI, underscoring the company's push for AI guardrails.

**State of play:** The bioresilience initiative — launched alongside Google's Isomorphic Labs — aims to to improve pathogen surveillance, accelerate vaccine and therapeutic design and strengthen outbreak responses.

- The company says it has built more than 15 partnerships over the past year with governments, biosecurity organizations and researchers.
- Google is also expanding access to its AI models and agents for trusted researchers, governments and biosecurity partners. Under its safety framework, those are considered "low-risk" restricted releases rather than public deployments.

**Zoom in:** "If... we were to find that we were reaching a critical capability level and we didn't have the appropriate mitigations, then we would not be launching,"Helen King, Google DeepMind's vice president of responsibility told Axios.

- She said that threshold has not yet been reached, citing evaluations Google runs throughout development.

**What they're saying:** "Everyone agrees we can't get this wrong," King said of AI's biological capabilities.

- Frontier AI labs are "in agreement" on the need for rigorous testing before model releases, Owen Larter, Google DeepMind's senior director of frontier AI policy and global affairs, told Axios.

**Zoom out:** The biosecurity effort aligns with the governance framework Hassabis proposed earlier this week.

- In an exclusive interview with Axios, Hassabis called for a more "systematic" approach to [AI regulation](https://www.axios.com/2026/07/10/alternative-playbook-ai-regulation) — funded by the industry, staffed by technical experts, and answerable to the U.S. government.
- Larter said he's hopeful the Trump administration's executive order process will produce a "durable framework" for testing frontier AI models before deployment.

**Catch up quick:** Google has become one of AI's biggest players in biology.

- AlphaFold, which predicts protein structures and helps scientists understand diseases and develop new drugs, earned Hassabis a share of the 2024 Nobel Prize in Chemistry.
- Isomorphic Labs is now commercializing that AI expertise for drug discovery.

**The bottom line:** Rather than framing biology solely as an AI safety problem, Google is increasingly arguing that frontier AI itself will become a critical biosecurity tool.

- email (opens in new window)
- sms (opens in new window)
- facebook (opens in new window)
	twitter (opens in new window)
	linkedin (opens in new window)
	bluesky (opens in new window)